Tumors

• CLINICAL_TRIALS trial_result · 2023-10-05
  Clinical Trial Update: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) [Phase 2]

  A Phase 2 clinical trial evaluating stereotactic ablative radiotherapy (SABR) for comprehensive treatment of oligometastatic tumors is ongoi…

• CLINICAL_TRIALS trial_result · 2023-08-08
  Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]

  A Phase 1/ Phase 2 trial evaluating HLX301, a TIGIT×PD-L1 bispecific, in locally advanced/metastatic solid tumors or lymphoma; current statu…

• CLINICAL_TRIALS trial_result · 2023-05-22
  Clinical Trial Update: A Study of PM1022 in Patients With Advanced Tumors [Phase 1, Phase 2]

  A phase 1/2 clinical trial investigating PM1022 in patients with advanced tumors; current status is UNKNOWN.

• CLINICAL_TRIALS trial_result · 2022-07-22
  Clinical Trial Update: Kypho-IORT: Intraoperative Radiotherapy During Kyphoplasty for Spinal Metastases [Phase 2]

  Phase 2 trial evaluating intraoperative radiotherapy during kyphoplasty for spinal metastases has been completed.

• CLINICAL_TRIALS trial_result · 2021-09-29
  Clinical Trial Update: Optimal Application Dose of Superficial Hyperthermia [Phase 3]

  A Phase 3 clinical trial update evaluating the optimal application dose of superficial hyperthermia for tumors has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-01-26
  Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]

  Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…

• CLINICAL_TRIALS trial_result · 2019-04-01
  Clinical Trial Update: Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) [Phase 1]

  Phase 1 dose-escalation trial of MK-2206 in locally advanced or metastatic solid tumors completed; results posted.

• CLINICAL_TRIALS trial_result · 2019-02-27
  Clinical Trial Update: A Study of IMC-A12 in Advanced Solid Tumors [Phase 1]

  Phase 1 study of IMC-A12 in advanced solid tumors has completed; results posted.

• CLINICAL_TRIALS trial_result · 2018-12-27
  Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]

  A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…